Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization

Cancer Research

Volumn 72, Issue 11, 2012, Pages 2720-2727

  Damania, Dhwanil ^a   Roy, Hemant K ^b   Subramanian, Hariharan ^a   Weinberg, David S ^c   Rex, Douglas K ^d   Goldberg, Michael J ^b   Muldoon, Joseph ^b   Cherkezyan, Lusik ^a   Zhu, Yuanjia ^a   Bianchi, Laura K ^b   Shah, Dhiren ^b   Pradhan, Prabhakar ^a   Borkar, Monica ^b   Lynch, Henry ^e   Backman, Vadim ^a  

^a Northwestern University   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOLOGY; DYSPLASIA; EPITHELIUM CELL; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN CELL; INTESTINE CELL; MAJOR CLINICAL STUDY; MALE; NANOCYTOLOGY; NANOIMAGING; PARTIAL WAVE SPECTROSCOPIC MICROSCOPY; PRECANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGE FACTORS; AGED; COLON; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MICROSCOPY; MIDDLE AGED; NANOSTRUCTURES; RECTUM; RISK FACTORS; SEX FACTORS;

EID: 84861858540     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3807     Document Type: Article

References (42)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
2. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351615355)
3. Cooper GS, Doug Kou T. Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries. Cancer 2008;112:293-9.
4. Roy HK, Backman V, Goldberg MJ. Colon cancer screening: the good, the bad, and the ugly. Arch Intern Med 2006;166:2177-9. (Pubitemid 44748763)
5. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8. (Pubitemid 41096630)
6. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14. (Pubitemid 39665324)
7. Song K, Fendrick AM, Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 2004;126:1270-9. (Pubitemid 38552791)
8. McCallion K, Mitchell RM, Wilson RH, Kee F, Watson RG, Collins JS, et al. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 2001;48:522-5. (Pubitemid 32234797)
9. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17.
10. Kopelovich L, Henson DE, Gazdar AF, Dunn B, Srivastava S, Kelloff GJ, et al. Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect. Clin Cancer Res 1999;5: 3899-905. (Pubitemid 30013763)
11. Bhutani M, Pathak AK, Fan Y-H, Liu DD, Lee JJ, Tang H, et al. Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila) 2008;1: 39-44.
12. Anti M, Marra G, Armelao F, Percesepe A, Ficarelli R, Ricciuto GM, et al. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 1993;34:525-30. (Pubitemid 23093497)
13. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, Sampliner RE, et al. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 1999;59:2353-7. (Pubitemid 29242282)
14. Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M, et al. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res 2004;64: 3694-700. (Pubitemid 38657950)
15. Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol 2007;40:142-50. (Pubitemid 46515191)
16. Polley AC, Mulholland F, Pin C, Williams EA, Bradburn DM, Mills SJ, et al. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res 2006;66:6553-62. (Pubitemid 44085610)
17. Kim JS, Pradhan P, Backman V, Szleifer I. The influence of chromosome density variations on the increase in nuclear disorder strength in carcinogenesis. Phys Biol. 2011;8:015004.
18. Subramanian H, Pradhan P, Liu Y, Capoglu IR, Li X, Rogers JD, et al. Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells. Proc Natl Acad Sci U S A 2008;105:20118-23.
19. Subramanian H, Pradhan P, Liu Y, Capoglu IR, Rogers JD, Roy HK, et al. Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. Opt Lett 2009;34:518-20.
20. Subramanian H, Roy HK, Pradhan P, Goldberg MJ, Muldoon J, Brand RE, et al. Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res 2009;69:5357-63.
21. Roy HK, Subramanian H, Damania D, Hensing TA, Rom WN, Pass HI, et al. Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res 2010;70:7748-54.
22. Damania D, Subramanian H, Tiwari AK, Stypula Y, Kunte D, Pradhan P, et al. Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. Biophys J 2010;99:989-96.
23. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates Inc.; 1988.
24. Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 2007;56:1585-9. (Pubitemid 350033198)
25. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32. (Pubitemid 36298000)
26. Butterly LF, Chase MP, Pohl H, Fiarman GS. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol 2006;4:343-8. (Pubitemid 43343891)
27. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999;36:801-18. (Pubitemid 29520569)
28. Brand RM, Jones DD, Lynch HT, Brand RE, Watson P, Ashwathnayaran R, et al. Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: influence of smoking. World J Gastroenterol 2006;12:4485-91. (Pubitemid 44256334)
29. Lewis JD, Ng K, Hung KE, Bilker WB, Berlin JA, Brensinger C, et al. Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med 2003;163:413-20. (Pubitemid 36241017)
30. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58: 5489-94. (Pubitemid 28551135)
31. Roy HK, Gomes AJ, Ruderman S, Bianchi LK, Goldberg MJ, Stoyneva V, et al. Optical measurement of rectal microvasculature as an adjunct to flexible sigmoidosocopy: gender-specific implications. Cancer Prev Res (Phila) 2010;3:844-51.
32. Kukitsu T, Takayama T, Miyanishi K, Nobuoka A, Katsuki S, Sato Y, et al. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res 2008;14: 48-54. (Pubitemid 351377977)
33. Alberts DS, Einspahr JG, Krouse RS, Prasad A, Ranger-Moore J, Hamilton P, et al. Karyometry of the colonic mucosa. Cancer Epidemiol Biomarkers Prev 2007;16:2704-16. (Pubitemid 351196327)
34. de Noo ME, Tollenaar RA, Deelder AM, Bouwman LH. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears. World J Gastroenterol 2006;12:6594-601. (Pubitemid 44794934)
35. Reymond MA, Steinert R, Kahne T, Sagynaliev E, Allal AS, Lippert H. Expression and functional proteomics studies in colorectal cancer. Pathol Res Pract 2004;200:119-27. (Pubitemid 38950441)
36. Weyn B, Jacob W, da Silva VD, Montironi R, Hamilton PW, Thompson D, et al. Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions. Cytometry 2000;41:133-8.
37. Verhest A, Kiss R, Dolne D, Larsimont D, Salmon I, Delaunoit Y, et al. Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analyses. Cancer 1990;65:2047-54. (Pubitemid 20147646)
38. Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H. Field defects in progression to gastrointestinal tract cancers. Cancer Lett 2008;260:1-10.
39. Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, Dvorakova K, et al. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 2004;25:681-92. (Pubitemid 38618519)
40. Pradhan P, Damania D, Joshi HM, Turzhitsky V, Subramanian H, Roy HK, et al. Quantification of nanoscale density fluctuations using electron microscopy: light-localization properties of biological cells. Appl Phys Lett 2010;97:243704.
41. Stypula Y, Crawford S, Subramanian H, Tiwari AK, Kunte D, Cornwell ML, et al. Understanding biological mechanisms of nuclear disorder strength in early carcinogenesis. Gastroenterology 2011;140:S765-6.
42. Sands BE, Grabert S. Epidemiology of inflammatory bowel disease and overview of pathogenesis. Med Health R I 2009;92:73-7.